Patents Assigned to Trigen Holdings AG Clareville House
  • Publication number: 20080166396
    Abstract: An oral dosage form of a compound selected from boronic acids which have a neutral thrombin (P1) domain linked to a hydrophobic moiety capable of binding to the thrombin (S2) and (S3) subsites, and salts, prodrugs and prodrug salts of such acids, the dosage form comprising a solid phase formulation comprising the compound and being adapted for reconstitution of the formulation to form a liquid preparation.
    Type: Application
    Filed: March 9, 2005
    Publication date: July 10, 2008
    Applicant: Trigen Holdings AG Clareville House
    Inventors: Guy Michael Patrick, Sophie Marie Combe-Marzelle, Anthony James Kennedy, Roger Withington, Oliver Vimpany Arnold Boucher